Strategy Driven by Innovation
Over 40 years of excellence in Research and Development
|
|
We devote € 67 million to R&D, accounting for over 9% of sales.
14% of our employees (over 500 people) work in R&D in centers in North America, France, Italy and Germany. |
|
|
Our multidisciplinary teams bring together researchers from different backgrounds to offer a broad range of technical and scientifi c expertise.
Our “engineer-physician intelligence networks” represent a continuous source of knowledge and ideas to develop |
|
|
We have forged partnerships with cardiology specialists at world renowned universities and research centers across the globe.
Our portfolio contains over 2,000 patents. |
Technology at the cutting edge
SORIN GROUP develops “smart” medical devices to save lives and improve patient comfort. Some of our recent developments include:
 |
 |
 |
|
OXYGENATOR KIDS D100 ™ is the smallest oxygenator on the market, specially designed to provide extra-corporeal circulation to newborns weighing less than 5 kg, during heart surgery. |
REMOTE MONITORING*
The SMARTVIEW™ remote |
SUTURELESS MINIMALLY INVASIVE HEART VALVE
VALVEPerceval™ S is a new selfanchoring sutureless aortic bioprothesis that is ideal for the replacement of diseased aortic |
SORIN GROUP is committed to continuous innovation through interdisciplinary structures of research and development. This is achieved by integrating science and technology into products and processes: from biology to medicine, materials science to electronics, micro-electronics and information technology.